Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis

Wu, JJ; Joshi, AA; Reddy, SP; Batech, M; Egeberg, A; Ahlehoff, O; Mehta, NN

Wu, JJ (reprint author), Kaiser Permanente Los Angeles Med Ctr, Dept Dermatol, Los Angeles, CA 90027 USA.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018; 32 (8): 1320

Abstract

BackgroundPsoriasis is a systemic chronic inflammatory condition associated with increased risk of cardiovascular disease. Data demonstrating that dec......

Full Text Link